Wako, Japan

Masakatsu Ozeki


Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 102(Granted Patents)


Location History:

  • Wako, JP (1980 - 1994)
  • Kawagoe, JP (1993 - 1996)

Company Filing History:


Years Active: 1980-1996

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Masakatsu Ozeki: Innovator in Thiazine Derivatives

Introduction

Masakatsu Ozeki is a prominent inventor based in Wako, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of thiazine derivatives. With a total of 12 patents to his name, Ozeki's work has had a substantial impact on the treatment of various neurological conditions.

Latest Patents

Ozeki's latest patents focus on thiazine (or oxazine) derivatives and their preparation. These compounds exhibit calcium antagonistic activity within cerebral tissues, making them useful for the prophylaxis and treatment of ischemic encephalopathy. His innovative formulations include derivatives where specific atoms and groups are defined, showcasing his expertise in chemical synthesis and pharmacology.

Career Highlights

Throughout his career, Ozeki has worked with notable companies such as Tanabe Seiyaku Company, Limited and Tanabe Seikayu Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Ozeki has collaborated with esteemed colleagues, including Ikuo Iijima and Kunihito Okumura. These partnerships have fostered a collaborative environment that has led to advancements in their shared field of research.

Conclusion

Masakatsu Ozeki's contributions to the field of medicinal chemistry, particularly through his innovative thiazine derivatives, highlight his role as a key inventor in the industry. His work continues to influence the development of treatments for neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…